Canada markets closed

Claritas Pharmaceuticals, Inc. (CLAZF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 03:22PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
Total Revenue
0
0
Operating Expenses
Research Development
-
-2,055
Selling General and Administrative
1,570
1,871
Total Operating Expenses
-485
-184
Operating Income or Loss
485
184
Interest Expense
768
225
Total Other Income/Expenses Net
-
-587
Income Before Tax
-3,079
-674
Income Tax Expense
-4,884
-4,884
Income from Continuing Operations
1,805
4,210
Net Income
-4,718
4,210
Net Income available to common shareholders
-4,718
4,210
Basic EPS
-0.13
0.16
Diluted EPS
-0.13
0.16
Basic Average Shares
30,967
26,691
Diluted Average Shares
30,967
26,691